Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising https://heathrbkn025660.weblogco.com/39203513/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide